Financial Year |
March 31 2023 |
Monetary Funds |
1,106,766,201.86 |
Held-for-trading Financial Assets |
330,628,938.81 |
Notes Receivable |
1,461,000.00 |
Accounts Receivable |
1,469,243,926.53 |
Advances to Suppliers |
79,423,372.88 |
Other Receivables |
32,576,110.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
598,400,419.18 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
60,615,034.69 |
Other Current Assets |
121,433,686.54 |
Total Current Assets |
4,094,949,245.02 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
72,557,102.94 |
Investment Properties |
62,028,277.77 |
Fixed Assetes |
383,098,378.24 |
Under-construction Projects |
211,060,465.95 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
60,188,522.27 |
R&D expenses |
-- |
Goodwill |
2,661,420.25 |
Long-Term Deferred and Prepaid Expenses |
47,999,664.84 |
Deferred Income Tax Assets |
59,637,469.69 |
Other Non-Current Assets |
305,297,795.92 |
Sub-Total of Non-Current Assets |
1,353,399,769.90 |
Total Assets |
5,448,349,014.92 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
159,195,618.55 |
Accounts Payable |
1,452,501,439.78 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
54,295,416.70 |
Taxes Payable |
8,158,869.30 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
7,563,302.56 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
40,043,701.27 |
Other Current Liabilities |
159,947,684.67 |
Sub-Total of Current Liabilities |
2,613,708,237.40 |
Long-term Loans |
2,554,135.50 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
87,297,020.39 |
Deferred Income Tax Liabilities |
5,729,937.61 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
267,862,094.46 |
Total Liabilities |
2,881,570,331.86 |
Paid-In Capital(Or Share Stock) |
187,943,462.00 |
Capital Surplus |
1,442,891,768.44 |
Surplus Reserve |
93,971,731.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
744,193,906.23 |
Minority Stockholder's Interest |
97,721,558.97 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,469,057,124.09 |
Owner's Equity(Stockholder's Equity) |
2,566,778,683.06 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,448,349,014.92 |